Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CVS Health Corp (CVS) vs Zoom Video Communications, Inc. (ZM) Price & Performance

CVS Health CorpTrade
Zoom Video Communications, Inc.Trade

Price performance (Past 24H)

Key statistics

CVS Health Corp vs Zoom Video Communications, Inc. — how do they compare? CVS Health Corp trades at $85.46 (market cap $112.29B), while Zoom Video Communications, Inc. trades at $95.24 (market cap $27.62B). The key difference: CVS Health Corp is far larger — about 4.1× Zoom Video Communications, Inc.'s market cap, and CVS Health Corp pays a 3.03% dividend while Zoom Video Communications, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Zoom Video Communications, Inc. for 92 Days on average.

CVSZM
Market Cap
$112.29B$27.62B
Volume
7,763,6763,913,188
Sector
HealthTechnology
52-Week High
$110.60$111.88
52-Week Low
$70.08$72.72
Typical Hold Time
83 Days92 Days
Enterprise Value
$174.64B$20.43B
Dividend Yield
3.03%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CVS Health Corp

CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.

The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.

Zoom Video Communications, Inc.

Zoom Communications (ZM) trades at $94.77, up 0.61% today, with a bullish technical signal supported by moving averages. The company reported strong profitability with a net income margin of 65.19% and ROE of 32.14% for 2026. Recent earnings beats in Q1 and Q2 2026, alongside AI-driven product launches like the Revenue OS, highlight growth momentum. Analyst consensus is a Buy with a $118.08 price target, though mixed sentiment persists with 55.1% Hold ratings.

The outlook for ZM is positive, driven by AI integration and earnings strength, but risks include reliance on international sales and competitive pressures. Upside potential exists if the company meets Q3 2026 EPS expectations of $1.50, though volatility near resistance at $95-$97 may challenge short-term gains.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CVS

No sentiment data available yet.

ZM
24% Buy76% Sell
Avg holding period · 92 Days

Top news

Latest headlines on both assets

About CVS Health Corp

Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.

Read more on CVS →

About Zoom Video Communications, Inc.

Zoom Video Communications, Inc. develops a people-centric cloud service that transforms real-time collaboration experience. The Company offers unified meeting experience, a cloud service that provides a 3-in-1 meeting platform with HD video conferencing, mobility, and web meetings. Zoom Video Communications serves customers worldwide.

Read more on ZM →